The transplanted liver graft is capable of clearing asymmetric dimethylarginine

Liver Transplantation

Volumn 10, Issue 12, 2004, Pages 1524-1530

  Siroen, Michiel P C ^a   Warlé, Michiel C ^b   Teerlink, Tom ^a   Nijveldt, Robert J ^a   Kuipers, Ernst J ^b   Metselaar, Herold J ^b   Tilanus, Hugo W ^b   Kuik, Dirk J ^a   van der Sijp, Joost R M ^a   Meijer, Sybren ^a   van der Hoven, Ben ^b   van Leeuwen, Paul A M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMPHOTERICIN B; ARGININE; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; CEFOTAXIME; COLISTIN; CYCLOSPORIN A; DIMETHYLARGININASE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; NORFLOXACIN; PREDNISONE; TACROLIMUS;

ACUTE GRAFT REJECTION; AMINO ACID METABOLISM; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME DEGRADATION; HUMAN; KIDNEY FUNCTION; LIVER BIOPSY; LIVER CLEARANCE; LIVER FAILURE; LIVER GRAFT; LIVER TRANSPLANTATION; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; URINARY EXCRETION; VOLUNTEER;

ACUTE DISEASE; ARGININE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHRONIC DISEASE; GRAFT REJECTION; HUMANS; KIDNEY; LIVER; LIVER FAILURE; LIVER TRANSPLANTATION; OSMOLAR CONCENTRATION; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES;

EID: 19944411787     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20286     Document Type: Article

References (26)

1. Böger RH. The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor. Cardiovasc Res 2003;59:824-833.
2. + carrier hCAT-2B. Nitric Oxide 1997;1:65-73.
3. Kakimoto Y, Akazawa S. Isolation and identification of N-G,N-G- and N-G,N′-G-dimethyl-arginine, N-epsilon-mono-, di-, and trimethyllysine, and glucosylgalactosyl- and galactosyl-delta-hydroxylysine from human urine. J Biol Chem 1970;245:5751-5758.
4. Kimoto M, Tsuji H, Ogawa T, Sasaoka K. Detection of NG,NG-dimethylarginine dimethylaminohydrolase in the nitric oxide-generating systems of rats using monoclonal antibody. Arch Biochem Biophys 1993;300:657-662.
5. Kimoto M, Whitley GS, Tsuji H, Ogawa T. Detection of NG,NG-dimethylarginine dimethylaminohydrolase in human tissues using a monoclonal antibody. J Biochem 1995;117:237-238.
6. Anderstam B, Katzarski K, Bergstrom J. Serum levels of NG, NG-dimethyl-L-arginine, a potential endogenous nitric oxide inhibitor in dialysis patients. J Am Soc Nephrol 1997;8:1437-1442.
7. Kielstein JT, Böger RH, Bode-Böger SM, Schaffer J, Barbey M, Koch KM, Frölich JC. Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: Relationship to treatment method and atherosclerotic disease. J Am Soc Nephrol 1999;10:594-600.
8. Nijveldt RJ, van Leeuwen PA, van Guldener C, Stehouwer CD, Rauwerda JA, Teerlink T. Net renal extraction of asymmetrical (ADMA) and symmetrical (SDMA) dimethylarginine in fasting humans. Nephrol Dial Transplant 2002;17:1999-2002.
9. Nijveldt RJ, Teerlink T, van Guldener C, Prins HA, van Lambalgen AA, Stehouwer CD, et al. Handling of asymmetrical dimethylarginine (ADMA) and symmetrical dimethylarginine (SDMA) by the rat kidney under basal conditions and during endotoxemia. Nephrol Dial Transplant 2003;18:2542-2550.
10. Vallance P, Leone A, Calvet A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992;339:572-575.
11. Zoccali C, Bode-Böger S, Mallamaci F, Benedetto F, Tripepi G, Malatino L, Cataliotti A, et al. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: A prospective study. Lancet 2001;358:2113-2117.
12. Carnegie PR, Fellows FC, Symington GR. Urinary excretion of methylarginine in human disease. Metabolism 1977;26:531-537.
13. Nijveldt RJ, Teerlink T, Siroen MP, van Lambalgen AA, Rauwerda JA, van Leeuwen PA. The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA). Clin Nutr 2003;22:17-22.
14. Nijveldt RJ, Teerlink T, van der Hoven B, Siroen MP, Kuik DJ, Rauwerda JA, van Leeuwen PA. Asymmetrical dimethylarginine (ADMA) in critically ill patients: High plasma ADMA concentration is an independent risk factor of ICU mortality. Clin Nutr 2003;22:23-30.
15. International Panel. Banff schema for grading liver allograft rejection: An international consensus document. Hepatology 1997;25:658-663.
16. Teerlink T, Nijveldt RJ, de Jong S, van Leeuwen PA. Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. Anal Biochem 2002;303:131-137.
17. Najbauer J, Johnson BA, Young AL, Aswad DW. Peptides with sequences similar to glycine, arginine-rich motifs in proteins interacting with RNA are efficiently recognized by methyltransferase(s) modifying arginine in numerous proteins. J Biol Chem 1993;268:10501-10509.
18. Jackson MJ, Beaudet AL, O'Brien WE. Mammalian urea cycle enzymes. Annu Rev Genet 1986;20:431-464.
19. Ikemoto M, Tsunekawa S, Tanaka K, Tanaka A, Yamaoka Y, Ozawa K, et al. Liver-type arginase in serum during and after liver transplantation: a novel index in monitoring conditions of the liver graft and its clinical significance. Clin Chim Acta 1998; 271:11-23.
20. Roth E, Steininger R, Winkler S, Langle F, Grunberger T, Fugget R, Muhlbacher F. L-Arginine deficiency after liver transplantation as an effect of arginase efflux from the graft. Influence on nitric oxide metabolism. Transplantation 1994;57:665-669.
21. Yagnik GP, Takahashi Y, Tsoulfas G, Reid K, Murase N, Geller DA. Blockade of the L-arginine/NO synthase pathway worsens hepatic apoptosis and liver transplant preservation injury. Hepatology 2002;36:573-581.
22. Martin-Sanz P, Olmedilla L, Dulin E, Casado M, Callejas NA, Perez-Pena J, et al. Presence of methylated arginine derivatives in orthotopic human liver transplantation: Relevance for liver function. Liver Transpl 2003;9:40-48.
23. Gary JD, Clarke S. RNA and protein interactions modulated by protein arginine methylation. Prog Nucleic Acid Res Mol Biol 1998;61:65-131.
24. Ito A, Tsao PS, Adimoolam S, Kimoto M, Ogawa T, Cooke JP. Novel mechanism for endothelial dysfunction: Dysregulation of dimethylarginine dimethylaminohydrolase. Circulation 1999;99:3092-3095.
25. Lin KY, Ito A, Asagami T, Tsao PS, Adimoolam S, Kimoto M, et al. Impaired nitric oxide synthase pathway in diabetes mellitus: Role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation 2002;106:987-992.
26. Murray-Rust J, Leiper J, McAlister M, Phelan J, Tilley S, Santa MJ, et al. Structural insights into the hydrolysis of cellular nitric oxide synthase inhibitors by dimethylarginine dimethylaminohydrolase. Nat Struct Biol 2001;8:679-683.